Goldman Sachs Group Inc Eli Lilly & CO Put Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $22.9 Million - $28.5 Million	-29,700 Reduced 26.93%	80,600 $71.4 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $27.9 Million - $35 Million	38,500 Added 53.62%	110,300 $99.9 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $58 Million - $77.6 Million	-98,000 Reduced 57.71%	71,800 $55.9 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $17.1 Million - $20.2 Million	-32,600 Reduced 16.11%	169,800 $99 Million
Q3 2023 May 14, 2024	BUY	$434.7 - $599.3 $14.2 Million - $19.5 Million	32,600 Added 19.2%	202,400 $109 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $31.1 Million - $42.9 Million	71,600 Added 54.74%	202,400 $109 Million
Q2 2023 May 14, 2024	BUY	$350.74 - $468.98 $26.2 Million - $35.1 Million	74,800 Added 133.57%	130,800 $61.3 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $26.2 Million - $35.1 Million	74,800 Added 133.57%	130,800 $61.3 Million
Q1 2023 May 14, 2024	SELL	$310.63 - $364.82 $10.3 Million - $12.1 Million	-33,200 Reduced 37.22%	56,000 $19.2 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $10.3 Million - $12.1 Million	-33,200 Reduced 37.22%	56,000 $19.2 Million
Q4 2022 May 14, 2024	SELL	$321.55 - $374.67 $9.39 Million - $10.9 Million	-29,200 Reduced 24.66%	89,200 $32.6 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $9.39 Million - $10.9 Million	-29,200 Reduced 24.66%	89,200 $32.6 Million
Q3 2022 May 14, 2024	SELL	$296.48 - $337.87 $8.3 Million - $9.46 Million	-28,000 Reduced 19.13%	118,400 $38.3 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $8.3 Million - $9.46 Million	-28,000 Reduced 19.13%	118,400 $38.3 Million
Q2 2022 May 14, 2024	SELL	$278.73 - $327.27 $6.52 Million - $7.66 Million	-23,400 Reduced 13.78%	146,400 $47.5 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $4.04 Million - $4.75 Million	-14,500 Reduced 9.01%	146,400 $47.5 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $4.18 Million - $5.19 Million	-17,800 Reduced 9.96%	160,900 $46.1 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $28.8 Million - $35.8 Million	128,300 Added 254.56%	178,700 $49.4 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $11.2 Million - $13.7 Million	50,400 New	50,400 $11.6 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$73 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.7 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.5 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account